The Spanish Federation for Rare Diseases (FEDER) and the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) have renewed their framework collaboration agreement, reaffirming their joint commitment to improving the lives, health, and care of the more than three million people living with rare diseases in Spain.